1. Home
  2. AIOT vs KROS Comparison

AIOT vs KROS Comparison

Compare AIOT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PowerFleet Inc.

AIOT

PowerFleet Inc.

HOLD

Current Price

$5.61

Market Cap

665.1M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$19.35

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIOT
KROS
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
665.1M
655.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AIOT
KROS
Price
$5.61
$19.35
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$10.50
$22.20
AVG Volume (30 Days)
1.1M
538.6K
Earning Date
02-09-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.57
Revenue
$425,867,000.00
$246,718,000.00
Revenue This Year
$23.71
$6,924.79
Revenue Next Year
$9.22
N/A
P/E Ratio
N/A
$11.80
Revenue Growth
92.93
37798.31
52 Week Low
$3.70
$9.12
52 Week High
$8.71
$22.55

Technical Indicators

Market Signals
Indicator
AIOT
KROS
Relative Strength Index (RSI) 60.78 49.54
Support Level $5.38 $17.51
Resistance Level $5.63 $18.85
Average True Range (ATR) 0.19 0.74
MACD 0.01 -0.36
Stochastic Oscillator 87.96 43.30

Price Performance

Historical Comparison
AIOT
KROS

About AIOT PowerFleet Inc.

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: